Related Experiment Video
Updated: May 10, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
PTEN controls β-cell regeneration in aged mice by regulating cell cycle inhibitor p16ink4a
Ni Zeng1, Kai-Ting Yang, Jennifer-Ann Bayan
1Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, 90089, USA.
Abstract:
Tissue regeneration diminishes with age, concurrent with declining hormone levels including growth factors such as insulin-like growth factor-1 (IGF-1). We investigated the molecular basis for such decline in pancreatic β-cells where loss of proliferation occurs early in age and is proposed to contribute to the pathogenesis of diabetes. We studied the regeneration capacity of β-cells in mouse model where PI3K/AKT pathway downstream of insulin/IGF-1 signaling is upregulated by genetic deletion of Pten (phosphatase and tensin homologue deleted on chromosome 10) specifically in insulin-producing cells. In this model, PTEN loss prevents the decline in proliferation capacity in aged β-cells and restores the ability of aged β-cells to respond to injury-induced regeneration. Using several animal and cell models where we can manipulate PTEN expression, we found that PTEN blocks cell cycle re-entry through a novel pathway leading to an increase in p16(ink4a), a cell cycle inhibitor characterized for its role in cellular senescence/aging. A downregulation in p16(ink4a) occurs when PTEN is lost as a result of cyclin D1 induction and the activation of E2F transcription factors. The activation of E2F transcriptional factors leads to methylation of p16(ink4a) promoter, an event that is mediated by the upregulation of polycomb protein, Ezh2. These analyses establish a novel PTEN/cyclin D1/E2F/Ezh2/p16(ink4a) signaling network responsible for the aging process and provide specific evidence for a molecular paradigm that explain how decline in growth factor signals such as IGF-1 (through PTEN/PI3K signaling) may control regeneration and the lack thereof in aging cells.
Insights
Aging reduces tissue regeneration due to declining growth factors like IGF-1. This study reveals PTEN loss in pancreatic cells prevents aging-related proliferation decline by inhibiting p16INK4a, restoring regeneration capacity.
Area of Science:
- Cellular biology
- Aging research
- Endocrinology
Background:
- Tissue regeneration capacity decreases with age, linked to reduced growth factors like insulin-like growth factor-1 (IGF-1).
- Pancreatic beta-cell proliferation loss in aging contributes to diabetes pathogenesis.
- The PI3K/AKT pathway, downstream of insulin/IGF-1 signaling, is crucial for cell growth and survival.
Purpose of the Study:
- To investigate the molecular mechanisms underlying age-related decline in pancreatic beta-cell regeneration.
- To explore the role of PTEN (phosphatase and tensin homologue deleted on chromosome 10) in regulating beta-cell proliferation and regeneration during aging.
- To identify novel signaling pathways involved in cellular senescence and the loss of regenerative capacity.
Main Methods:
- Utilized a mouse model with genetic deletion of PTEN specifically in insulin-producing cells.
- Employed various animal and cell models to manipulate PTEN expression.
- Analyzed cell cycle regulation, gene expression (p16INK4a, cyclin D1), transcription factor activity (E2F), and epigenetic modifications (DNA methylation, Ezh2 activity).
Main Results:
- Genetic deletion of PTEN in pancreatic beta-cells prevented the age-associated decline in proliferation.
- PTEN loss restored the regenerative capacity of aged beta-cells following injury.
- Identified a novel PTEN/cyclin D1/E2F/Ezh2/p16INK4a signaling network where PTEN normally promotes aging by upregulating p16INK4a, a cell cycle inhibitor.
Conclusions:
- PTEN acts as a key regulator of cellular aging in pancreatic beta-cells by controlling the p16INK4a pathway.
- The identified signaling network provides a molecular explanation for how declining growth factor signaling (e.g., IGF-1) contributes to impaired regeneration in aging cells.
- Targeting this PTEN-mediated pathway may offer therapeutic strategies to enhance tissue regeneration and combat age-related diseases like diabetes.
More Related Videos
09:31In Vitro Colony Assays for Characterizing Tri-potent Progenitor Cells Isolated from the Adult Murine Pancreas
Published on: June 10, 2016
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
Related Concept Videos
Inhibition of Cdk Activity
Cell Specific Gene Expression
Negative Regulator Molecules
Tissue Renewal without Stem Cells
However, failure of such a system...
Abnormal Proliferation
Replicative Cell Senescence